Aurealis Pharma
Kuopio
About Aurealis Pharma
Aurealis Pharma is a biopharmaceutical company aiming at developing ground-breaking medicines for the treatment of cancer and chronic wounds. They are dedicated in the R&D of gene and cell based therapies, as well as the development of new active molecules by computational modeling of nature derived compounds. Their key strategy is to perform outstanding interdisciplinary R&D and to implement these into new business models. They are actively seeking for collaborations with pharmaceutical companies, academic research institutions and pre-clinical CROs.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $10K – $50K
- Total funding: $13.6M
- Funding stage: Early Stage Venture
- Last round: Series B (Feb 2019)
- Website: aurealispharma.com
- Phone: +358458433550
Industries & Categories
Biotechnology, Health Care, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/aurealis-pharma-105891 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.